These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9301684)

  • 21. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
    Richon VM; Rifkind RA; Marks PA
    Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
    Chen Z; Banks J; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):471-5. PubMed ID: 6952199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PU.1 is dispensable to block erythroid differentiation in Friend erythroleukemia cells.
    Fernández-Nestosa MJ; Hernández P; Schvartzman JB; Krimer DB
    Leuk Res; 2008 Jan; 32(1):121-30. PubMed ID: 17586044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in CuZn-superoxide dismutase during induced differentiation of murine erythroleukemia cells.
    Paoletti F; Mocali A
    Cancer Res; 1988 Dec; 48(23):6674-7. PubMed ID: 3180077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA; Rifkind RA
    Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythroleukemia cells: variants inducible for hemoglobin synthesis without commitment to terminal cell division.
    Marks PA; Chen Z; Banks J; Rifkind RA
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2281-4. PubMed ID: 6572977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of urokinase with specific receptors abolishes the time of commitment to terminal differentiation of murine erythroleukaemia (Friend) cells.
    Del Rosso M; Pucci M; Fibbi G; Dini G
    Br J Haematol; 1987 Jul; 66(3):289-94. PubMed ID: 3040071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
    Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
    Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular factors involved in erythroid differentiation of mouse erythroleukaemia cells.
    Watanabe T; Nomura S; Kaneko T; Yamagoe S; Oishi M
    IARC Sci Publ; 1988; (92):43-53. PubMed ID: 3235155
    [No Abstract]   [Full Text] [Related]  

  • 31. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S; Scher BM; Hellinger N; Scher W
    Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases.
    Watanabe T; Kondo K; Oishi M
    Cancer Res; 1991 Feb; 51(3):764-8. PubMed ID: 1988116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of erythroid differentiation by inhibition of Ras/ERK pathway in a friend murine leukemia cell line.
    Matsuzaki T; Aisaki Ki; Yamamura Y; Noda M; Ikawa Y
    Oncogene; 2000 Mar; 19(12):1500-8. PubMed ID: 10734309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bis-pyrrolyl-tetrazolyl derivatives as hybrid polar compounds: A case of lipophilic functional bioisosterism with bis-acetamides.
    Chatzopoulou M; Bonovolias ID; Nicolaou I; Demopoulos VJ; Vizirianakis IS; Tsiftsoglou AS
    Eur J Med Chem; 2012 Apr; 50():75-80. PubMed ID: 22341896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. cAMP-dependent phosphorylation and hexamethylene-bis-acetamide induced dephosphorylation of p19 in murine erythroleukemia cells.
    Scheele JS
    Mol Cell Biochem; 1998 Aug; 185(1-2):55-63. PubMed ID: 9746212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of murine erythroleukemic cell differentiation by inhibitors of polyamine biosynthesis.
    Meilhoc E; Moutin MJ; Osborne HB
    J Cell Physiol; 1987 Jun; 131(3):465-71. PubMed ID: 3110176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear protein kinase C activity is decreased in Friend erythroleukemia cells induced to differentiate.
    Beckman BS
    Exp Hematol; 1992 Mar; 20(3):324-7. PubMed ID: 1568447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
    Gallagher AP; Burnett AK; Bowen DT; Darley RL
    Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the mechanism of action of hexamethylene bisacetamide, a potent inducer of erythroleukemic differentiation.
    Reuben RC
    Biochim Biophys Acta; 1979 Dec; 588(3):310-21. PubMed ID: 292456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
    Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
    Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.